Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07026591

Epilepsy and Driving

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Epilepsy can lead to cognitive impairments, particularly in attention, which may affect daily activities such as driving. Driving plays a key role in maintaining autonomy and is essential for the social and professional integration of people with epilepsy. Therefore, assessing fitness to drive is a major issue for individuals with epilepsy. French legislation governing driving for people with epilepsy clearly outlines the periods during which a person is not permitted to drive. However, the means or methods for evaluating driving fitness in these individuals are not well defined. Currently, assessment is based more on a medical consultation than on a comprehensive evaluation of driving ability. Using a driving simulator in combination with an EEG could be a valuable approach to better assess the impact of epilepsy-related cognitive impairments on driving performance.

Conditions

Timeline

Start date
2025-11-06
Primary completion
2027-11-01
Completion
2027-11-01
First posted
2025-06-18
Last updated
2025-12-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07026591. Inclusion in this directory is not an endorsement.

Epilepsy and Driving (NCT07026591) · Clinical Trials Directory